JENIFER MCHALE: Open Payments
NPI 1881351922 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 29 payments from 11 companies in 2025. Trend: 2023 $422 · 2024 $484 · 2025 $577
Food & beverage: $577
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $257 |
| Novo Nordisk Inc | 4 | $74 |
| Lilly USA, LLC | 3 | $47 |
| Astellas Pharma US Inc | 2 | $44 |
| Eisai Inc. | 1 | $35 |
| Amgen Inc. | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Boston Scientific Corporation | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $15 |
Products named: QULIPTA, Ozempic, MOUNJARO, Veozah, UBRELVY, Leqembi, XIFAXAN, Rybelsus.
Industry payments across FL — which companies pay providers there.
